Pharmaceuticals Projects in India – Page 26

1,542 upcoming and ongoing pharmaceuticals projects in India worth ₹665,172 Cr, with investment, location, project stage and latest status. Last updated 08 Oct 2026.

Projects tracked
1,542
Total investment
₹665,172 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
14

Latest pharmaceuticals projects in India

Showing 126–130 of 1,542
  1. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.5900 Million Pharma Mfg. Unit in Lucknow, Uttar Pradesh

    Uttar Pradesh From 5000 Million to 49999 Million

    A pharmaceutical manufacturing and R&D hub is proposed in the Lucknow–Raebareli region of Uttar Pradesh. The project aims to establish integrated production and research facilities with an estimated investment of ₹5,900 million. As of February 2026, a memorandum of understanding has been signed with the state government, and the project is currently in the pre-execution stage, awaiting statutory and regulatory clearances.

    View project
  2. Under Implementation Pharmaceuticals Projects Updated

    New Pharma Intermediates Mfg. Unit in Pune, Maharashtra

    Maharashtra Less than 100 Million

    A chemical company plans a new pharma intermediates and synthetic organic hormone chemicals manufacturing unit in Pune, Maharashtra, with a capacity of 1,215 TPA. The project, costing ₹60 million, is scheduled for construction from July 2026 to June 2027. As of February 2026, the proposal has been submitted to the State Level Environment Impact Assessment Authority for environmental clearance.

    View project
  3. Under Implementation Pharmaceuticals Projects Updated

    Rs.500 Million API And API Intermediate Products Mfg. Expansion Project in Palghar, Maharashtra

    Maharashtra From 100 Million to 999 Million

    A pharmaceutical company plans an expansion project for manufacturing APIs and intermediates in Maharashtra, increasing capacity from 14,688 TPA to 45,641.52 TPA. The project, costing ₹500 million, will start construction in November 2025 and conclude by June 2026. As of February 2026, the proposal has been submitted to the State Level Environment Impact Assessment Authority for clearance.

    View project
  4. Under Implementation Pharmaceuticals Projects Updated

    Rs.1350 Million New Active Pharma Ingredients Mfg. Unit in Tirunelveli, Tamil Nadu

    Tamil Nadu From 1000 Million to 4999 Million

    A pharmaceutical firm plans to establish a new Active Pharmaceutical Ingredients manufacturing unit at Gangaikondan, Tirunelveli, Tamil Nadu. The facility will produce bulk drugs and intermediates with a capacity of 8,760 TPA. The project cost is Rs. 1,350 million. Construction is scheduled from May 2026 to February 2028, with environmental clearance under review by the state authority as of February.

    View project
  5. Under Implementation Pharmaceuticals Projects Updated

    Bulk Drugs and Bulk Drug Intermediates Mfg. Expansion Project in Bharuch, Gujarat

    Gujarat Less than 100 Million

    A chemical manufacturing unit in Gujarat plans to expand by producing synthetic organic chemicals, including bulk drugs and intermediates, with an additional capacity of 315 TPA. The Rs. 77 million project is scheduled for construction from October 2026 to October 2027 and is under review by the State Level Environment Impact Assessment Authority as of January 2026.

    View project